C12R 2001/385
Pseudomonas aeruginosa
C12R2001/385 (Pseudomonas aeruginosa) appears on 68 US grants and 85 published applications in this corpus.
Search patents in C12R- Granted patents
- 68
- Published applications
- 85
- Assignees
- 81
- Inventors
- 225
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 4 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 2 | 2 |
| 2009 | 0 | 2 |
| 2010 | 2 | 2 |
| 2011 | 3 | 2 |
| 2012 | 0 | 4 |
| 2013 | 5 | 2 |
| 2014 | 1 | 1 |
| 2015 | 2 | 2 |
| 2016 | 2 | 6 |
| 2017 | 5 | 2 |
| 2018 | 2 | 0 |
| 2019 | 2 | 3 |
| 2020 | 1 | 5 |
| 2021 | 2 | 1 |
| 2022 | 1 | 11 |
| 2023 | 3 | 11 |
| 2024 | 4 | 8 |
| 2025 | 5 | 14 |
| 2026 | 4 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Application of alkali-tolerant microbial bacteria PDC-1 and its in-situ remediation of organic contaminated soil in mining areas22 Sep 2026US 12,742,148 B2Chinese Research Academy of Environmental Sciences
- Bacterial membrane vesicles, and separation and preparation system and method therefor9 Jun 2026US 12,648,990 B2Sichuan University
- Antibodies specifically recognizing Pseudomonas Psl and uses thereof10 Mar 2026US 12,570,727 B2Beijing Solobio Genetechnology Company Ltd.
- Devices and methods for modulating ADMA in blood27 Jan 2026US 12,533,401 B2The Trustees of Indiana University
- Method for preparing (s)-1,2,3,4-tetrahydroisoquinoline-1 carboxylic acid and derivatives thereof25 Nov 2025US 12,480,148 B2Tongli Biomedical Co., Ltd.
- Multivalent vaccine compositions and uses thereof23 Jul 2026US 2026/0207726 A1Glaxosmithkline Biologicals SA
- Cells and method for producing rhamnolipids using alternative glucose transporters16 Jul 2026US 2026/0201431 A1Evonik Operations GmbH
- Compositions and particles for payload delivery30 Apr 2026US 2026/0116928 A1Thornhill Therapeutics, Inc.
- Engineered bacteria and methods of producing sustainable biomolecules2 Apr 2026US 2026/0092249 A1President and Fellows of Harvard College
- Methods and cells for the production of fluorinated compounds25 Dec 2025US 2025/0388936 A1Danmarks Tekniske Universitet
Most cited
By later US patents
- Immobilization of biological cells in polytetrafluoroethylene matrix41US 4,722,898 AMinnesota Mining and Manufacturing Company · 1988
- Pseudomonas compositions38US 4,452,894 AMicrolife Genetics, Inc. · 1984
- Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa36US 4,578,458 AThe Brigham and Women S Hospital, Inc. · 1986
- Microbiological process for removing oleaginous material from wastewater and microbiological combination capable of same22US 4,288,545 ASybron Corporation · 1981
- Immobilization of biological cells in polytetrafluoroethylene matrix21US 4,871,671 AMinnesota Mining and Manufacturing Company · 1989